3,4-Dichlorobenzotrifluoride Pharmaceutical Grade from Japan
Pharmaceutical-grade 3,4-Dichlorobenzotrifluoride with <10ppm heavy metals, used in synthesis of anti-cancer drug intermediates. Meets HTS 2903.99.08.00 as explicitly named halogenated aromatic hydrocarbon under chapter 29 pure compound provisions.
Duty Rate — Japan → United States
12.5%
Rate breakdown
9903.05.4912.5%Except for products described in headings 9903.05.85–9903.05.92, articles the product of Japan, with an ad valorem (or ad valorem equivalent) rate of duty under column 1 less than 12.5 percent, as provided for in U.S. note 52 to this subchapter
Import Tips
• Provide Certificate of Analysis (CoA) with ICH Q3D elemental impurities testing results
• Declare under FDA prior notice if destined for US pharmaceutical manufacturing
• Use EP/USP stabilizer-free packaging to maintain chapter 29 classification